Focused assessment for chronic pain and related symptoms.
Medical cannabis may be considered as part of symptom management for selected patients. At Elements Medical Collective, eligibility is determined through a clinical assessment that weighs potential benefits, risks, patient goals, and medical history.
Chronic & neuropathic pain
Including chronic non-cancer pain, neuropathic pain, refractory back or neck pain, arthritis-related symptoms, fibromyalgia, and headaches or migraines.
Sleep disturbance
Assessment may include sleep difficulty related to chronic pain or other persistent symptoms, with emphasis on realistic expectations and safe dosing.
Neurological symptoms
Including selected patients with spasticity, multiple sclerosis-related symptoms, or spinal cord injury-related symptom burden.
Oncology & palliative care
Assessment may be appropriate for cancer-related pain, chemotherapy-related nausea, appetite concerns, or palliative symptom management.
Anxiety-related or PTSD symptoms
When relevant to chronic medical conditions, assessment is cautious and individualized, with careful screening for risk factors.
Other complex symptoms
Selected patients may be referred for other chronic symptoms where cannabinoid therapy is being considered by the referring clinician.
Elements Medical Collective 